Indegene Ltd 的股票首次亮相时比孟买证券交易所 (BSE) 溢价 46%，比国家证券交易所 (NSE) 溢价 45%，其 IPO 认购倍数为 69.71 倍。 Indegene Ltd's shares debuted with a 46% premium on BSE, 45% on NSE, and its IPO was subscribed 69.71 times.

医疗科技公司 Indegene Ltd 的股票在孟买证券交易所 (BSE) 首次上市，溢价 46%，在国家证券交易所 (NSE) 溢价 45%。 Healthcare tech firm Indegene Ltd's shares debuted on the stock exchanges with a premium of 46% on BSE and 45% on NSE. 该公司首次公开发行股票（IPO）在竞标截止日就获得了69.71倍的认购倍数。 The company's Initial Public Offer (IPO) was subscribed 69.71 times on the closing day of bidding. 此次 IPO 募资 1,841.75 千万卢比，新发行股票金额高达 760 千万卢比，并发售最多 2,39,32,732 股普通股。 The Rs 1,841.75 crore IPO had a fresh issue of up to Rs 760 crore and an offer-for-sale of up to 2,39,32,732 equity shares. 新发行所筹集的资金将用于偿还债务、资本支出需求和其他一般公司用途。 The funds raised from the fresh issue will be used for debt repayment, capital expenditure requirements, and other general corporate purposes.